Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Chardan Capital Markets
Recent news which mentions Chardan Capital Markets
< Previous
1
2
Next >
Chardan: R1 RCM Will Make A Full Recovery
September 04, 2018
Tickers
RCM
Tags
Analyst Ratings
Benzinga
Initiation
From
Benzinga
Expect More Downside In Axovant Sciences
October 05, 2017
Tickers
AXON
Tags
Short Ideas
clinical trials
Analyst Color
From
Benzinga
Straight Path Crossed: Speculative Short To M&A Darling, A Look Back At StraightPath Communications Journey
May 08, 2017
Tickers
DISH
GSAT
NEWS
STRP
Tags
Sahm Adrangi
DISH
News
From
Benzinga
Did Globalstar Deserve To Move Higher On Straight Path Takeover News?
April 11, 2017
Tickers
GSAT
NEWS
STRP
T
Tags
GSAT
STRP
Analyst Color
From
Benzinga
4 Reasons Why 2017 Will Be A Pivotal Year For Vuzix
March 20, 2017
Tickers
TECH
VUZI
Tags
Analyst Color
Chardan Capital Markets
iWear
From
Benzinga
AveXis Offers Easily The Best Treatment Option For SMA Type-1 Patients
March 17, 2017
Tickers
AVXS
Tags
Gbola Amusa
Citron Research
Analyst Color
From
Benzinga
Vuzix's Accelerated Sales Ramp Should Continue In 2017
March 17, 2017
Tickers
TECH
VUZI
Tags
Trading Ideas
Reiteration
Analyst Ratings
From
Benzinga
Clovis Shares Reiterated As A Sell Following 10% Rally
March 15, 2017
Tickers
AZN
CLVS
Tags
Rubraca
Trading Ideas
Analyst Ratings
From
Benzinga
Chardan Analyst Suggests An AveXis-Ionis Pair Trade
February 06, 2017
Tickers
AVXS
BIIB
IONS
Tags
Health Care
Benzinga
Reiteration
From
Benzinga
Social Reality Wins A Buy Rating, $9 Price Target From Chardan
February 01, 2017
Tickers
SRAX
Tags
Benzinga
Initiation
Analyst Ratings
From
Benzinga
Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April
January 10, 2017
Tickers
AMGN
NEWS
REGN
SNY
Tags
Benzinga
Reiteration
Legal
From
Benzinga
Despite Guidance Miss, Teladoc Still Attractive
January 09, 2017
Tickers
NEWS
TDOC
TECH
Tags
Benzinga
Reiteration
Guidance
From
Benzinga
5 Key Takeaways In Regeneron's Praluent Suit, Steps Forward
January 06, 2017
Tickers
AMGN
NEWS
REGN
SNY
Tags
Analyst Ratings
General
SNY
From
Benzinga
The Medicines Company Is A Top Pick For 2017
January 06, 2017
Tickers
ALNY
AMGN
MDCO
NEWS
Tags
Movers
Biotech
AMGN
From
Benzinga
Reasons To Stay Bullish On Alnylam In The New Year
December 19, 2016
Tickers
ALNY
NEWS
SNY
Tags
Biotech
Movers
SNY
From
Benzinga
For Arbutus' Hepatitis B Treatment, 'Liver Safety Risk Overwhelms Promising Efficacy'
December 13, 2016
Tickers
ABUS
ALNY
NEWS
Tags
Biotech
Movers
General
From
Benzinga
Chardan Upgrades Regeneron; Cites Fovista Failure, Stock's Recent Underperformance
December 12, 2016
Tickers
AMGN
NEWS
OPHT
REGN
Tags
Analyst Ratings
General
SNY
From
Benzinga
Chardan Downgrades Ophthotech As Fovista Fails Phase III Trials For Wet AMD
December 12, 2016
Tickers
NEWS
OPHT
Tags
Analyst Ratings
General
OPHT
From
Benzinga
4 Possible Catalysts On Eyegate's Horizon
December 06, 2016
Tickers
EYEG
Tags
Reiteration
Benzinga
Health Care
From
Benzinga
Chardan: Watch Wearable Maker Vuzix Into CES
December 05, 2016
Tickers
NEWS
TECH
VUZI
Tags
James McIlree
Trading Ideas
Previews
From
Benzinga
Alnylam Is Now The Leader In The Clinical HBV RNAi Therapy Space
November 30, 2016
Tickers
ABUS
ALNY
ARWR
NEWS
Tags
ALNY
Analyst Color
Chardan Capital Markets
From
Benzinga
WageWorks Shares Could Rise 16% Over Next Year
November 30, 2016
Tickers
WAGE
Tags
Analyst Color
Chardan Capital Markets
Steven Wardell
From
Benzinga
Arrowhead Pharma Downgraded Following EX-1 RNAi Program Discontinuations
November 29, 2016
Tickers
ARWR
Tags
Price Target
Chardan Capital Markets
Analyst Color
From
Benzinga
Amicus Therapeutics: Here's The Good News
November 29, 2016
Tickers
FOLD
NEWS
Tags
Long Ideas
Analyst Ratings
General
From
Benzinga
Teladoc Shares Could Rise 40% Over The Next Year
November 16, 2016
Tickers
TDOC
Tags
Long Ideas
Benzinga
Initiation
From
Benzinga
Chardan Recommends Selling Clovis Oncology
October 25, 2016
Tickers
CLVS
Tags
CLVS
Initiation
Benzinga
From
Benzinga
Novartis A Buy At Chardan
September 20, 2016
Tickers
NVS
Tags
Gbola Amusa
Biotech
Long Ideas
From
Benzinga
3 Turnaround Stories Getting Love From Sell-Side Analysts
August 09, 2016
Tickers
COH
IPAS
TMUS
Tags
Chardan Capital Markets
Analyst Color
TMUS
From
Benzinga
Chardan Analyst Believe iPass' Turnaround Strategy Is Working
August 04, 2016
Tickers
IPAS
Tags
IPAS
James McIlree
Chardan Capital Markets
From
Benzinga
Weak Competition, Favorable Regulatory Environment Among Tailwinds For Sunworks
August 04, 2016
Tickers
SUNW
Tags
Benzinga
Initiation
Trading Ideas
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.